Bandingkan Harga & Kinerja PAM Mineral Tbk. (NICL) vs Organon Pharma Indonesia Tbk. (SCPI)
Kinerja harga (24 Jam Terakhir)
Statistik utama
Statistik utama
Perbedaan PAM Mineral Tbk. dan Organon Pharma Indonesia Tbk.: PAM Mineral Tbk. diperdagangkan di Rp468 (kapitalisasi pasar 5,19 T, volume 24 jam 46,38 jt), sedangkan Organon Pharma Indonesia Tbk. diperdagangkan di Rp29.000 (kapitalisasi pasar 104,4 M). Perbedaan utamanya: PAM Mineral Tbk. jauh lebih besar — sekitar 49,7× kapitalisasi pasar Organon Pharma Indonesia Tbk.. Mana yang lebih baik tergantung tujuan investasimu.
| NICL | SCPI | |
|---|---|---|
Kapitalisasi Pasar | 5,19 T | 104,4 M |
Volume | 46,38 jt | — |
Lot | 463,81 rb | — |
Perputaran | 21,73 M | — |
Harga Rata-rata | 468,61 | — |
Nilai Transaksi | 21,73 M | — |
Harga Ekuilibrium Indikatif | 468 | — |
Volume Ekuilibrium Indikatif | 1,83 rb | — |
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Berita terkini
Berita terbaru kedua aset
Berita terkini
Berita terbaru kedua aset
Tentang PAM Mineral Tbk.
PT PAM Mineral Tbk (the Company) was established on January 15, 2008 based on Notarial Deed No. 32 of Edison Jingga, S.H., notary in Jakarta. The Company operates in two operational areas, namely in Southeast Sulawesi, Lameruru Village, Langgikima District, North Konawe Regency and Laroenai Village, Bungku Pesisir District, Central Sulawesi.
Selengkapnya di halaman NICL →Tentang Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Selengkapnya di halaman SCPI →
